INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO
In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.
-
How Sponsors Can Leverage New Technologies To Lower Trial Costs
This study introduces sponsors to an innovative, lean, and efficient approach to data management that integrates site-facing technologies to streamline trial operations.
-
Targeted Protein Degraders: Transforming Oral Therapeutics
CDMOs play a critical role in TPD development by offering specialized infrastructure and analytical capabilities to support the transition from preclinical research to clinical supply and commercialization.
-
Stipends Create More Tax Burden — Here's A Better Option
Explore the tax reporting requirements, including the threshold for payments requiring a 1099 form rising from $600 to $2,000 in 2026.
-
Developing Community-Based And Trial-Naïve Sites: The Real ROI9/9/2025
Trial-naïve sites, when supported with infrastructure, training, and network integration, represent a critical yet underused opportunity to expand patient access and accelerate recruitment.
-
Breaking Down Operational And Financial Complexity In Clinical Trials12/8/2025
Consider how factors like hybrid visits, enrollment patterns, and variable procedure volumes shape both the cadence and magnitude of site payments, supplier activity, and patient-related expenses.
-
Clinical, Commercial Packaging: Delivering Next-Gen Therapies4/7/2026
See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.
-
Consolidating Access Into A Single Platform: A Site CEO's Perspective2/28/2025
By providing research sites with a unified, streamlined interface, we can reduce operational friction, enhance collaboration, and ultimately accelerate the development of new therapies.
-
Maximizing Site Performance: The Hidden Benefits Of Unified eConsent And EDC12/6/2024
Disconnected systems for eConsent and EDC create inefficiencies that burden clinical trial teams, but modern integrated platform solutions are streamlining operations.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
-
Built for Sites, Not Just Sponsors
Too many recruitment vendors focus solely on the sponsor’s bottom line, leaving sites stuck managing clunky spreadsheets, manual tracking, and outreach tasks without the infrastructure to scale.
-
Highly potent APIs require stringent containment and precise manufacturing controls. Specialized facilities offer end-to-end development solutions and robust cross-contamination protections.
-
Our Approach
At Southern Star Research, we have extensive experience across all aspects of clinical operations and a wide range of therapeutic areas. We specialize in providing flexible, high-quality, and custom solutions that help you deliver regulator-ready data on time and at a predictable price.
As a large proportion of our clients are geographically dispersed, we understand how important it is to be able to trust that your CRO is working in your best interests. That’s why we pride ourselves on building strong, transparent, and close relationships with our clients.
Our team of experts will guide you through the clinical trial process using a proactive and collaborative approach, ensuring that your stakeholders are always informed, in control, and confident throughout the journey.